Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
4.470
+0.250 (5.92%)
At close: Nov 6, 2026, 4:00 PM EST
4.521
+0.051 (1.13%)
Pre-market: Nov 9, 2026, 8:10 AM EST
Precigen Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 156.94 | 9.68 | 3.93 | 6.23 | 26.66 | 13.77 |
Other Revenue | - | - | - | - | 0.25 | 0.5 |
| 156.94 | 9.68 | 3.93 | 6.23 | 26.91 | 14.27 | |
Revenue Growth | 2387.61% | 146.73% | -36.95% | -76.87% | 88.61% | -55.40% |
Cost of Revenue | 40.01 | 46.16 | 57.34 | 54.73 | 53.51 | 53.68 |
Gross Profit | 116.93 | -36.47 | -53.41 | -48.51 | -26.6 | -39.41 |
Selling, General & Admin | 83.3 | 70.13 | 41.29 | 40.42 | 48.01 | 51.99 |
Operating Expenses | 83.3 | 70.13 | 41.29 | 40.42 | 48.01 | 51.99 |
Operating Income | 33.63 | -106.6 | -94.71 | -88.92 | -74.61 | -91.41 |
Interest Expense | -11.82 | -3.87 | -0.01 | -0.47 | -6.77 | -18.76 |
Interest & Investment Income | 2.44 | 3.22 | 1.42 | 3.24 | 0.13 | 0.17 |
Earnings From Equity Investments | - | - | - | - | 0.86 | -0 |
Currency Exchange Gain (Loss) | - | - | -2.92 | - | - | - |
Other Non Operating Income (Expenses) | 0.65 | -139.48 | 0 | 0.63 | 1.54 | -0.43 |
EBT Excluding Unusual Items | 24.9 | -246.73 | -96.2 | -85.53 | -78.85 | -110.42 |
Impairment of Goodwill | - | -3.91 | -7.41 | -10.39 | -0.48 | - |
Gain (Loss) on Sale of Assets | - | - | 8.5 | - | - | - |
Asset Writedown | - | - | -32.92 | -0.45 | -0.64 | -0.54 |
Legal Settlements | -0.29 | - | - | - | - | - |
Pretax Income | 24.61 | -250.64 | -128.03 | -96.36 | -79.97 | -110.97 |
Income Tax Expense | 0.2 | 0 | -1.79 | -0.46 | -0.19 | -0.16 |
Earnings From Continuing Operations | 24.41 | -250.64 | -126.24 | -95.9 | -79.78 | -110.81 |
Earnings From Discontinued Operations | - | - | - | - | 108.09 | 18.64 |
Net Income to Company | 24.41 | -250.64 | -126.24 | -95.9 | 28.32 | -92.17 |
Net Income | 24.41 | -250.64 | -126.24 | -95.9 | 28.32 | -92.17 |
Preferred Dividends & Other Adjustments | - | 179 | - | - | - | - |
Net Income to Common | 24.41 | -429.64 | -126.24 | -95.9 | 28.32 | -92.17 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 356 | 313 | 268 | 245 | 200 | 198 |
Shares Outstanding (Diluted) | 400 | 313 | 268 | 245 | 200 | 198 |
Shares Change | 34.42% | 16.90% | 9.48% | 22.05% | 1.31% | 18.37% |
EPS (Basic) | 0.07 | -1.37 | -0.47 | -0.39 | 0.14 | -0.47 |
EPS (Diluted) | 0.07 | -1.37 | -0.47 | -0.39 | 0.14 | -0.47 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -74.32 | -89.83 | -76.76 | -68.47 | -69.97 | -63.02 |
Free Cash Flow Per Share | -0.19 | -0.29 | -0.29 | -0.28 | -0.35 | -0.32 |
Gross Margin | 74.51% | - | - | - | -98.85% | -276.24% |
Operating Margin | 21.43% | -1100.78% | -2412.87% | -1428.48% | -277.25% | -640.67% |
Profit Margin | 15.55% | -4436.62% | -3216.18% | -1540.63% | 105.23% | -646.01% |
Free Cash Flow Margin | -47.35% | -927.57% | -1955.59% | -1099.86% | -260.02% | -441.70% |
EBITDA | 38.08 | -103.4 | -90.18 | -82.26 | -67.42 | -77.64 |
EBITDA Margin | 24.26% | - | - | - | -250.53% | - |
D&A For EBITDA | 4.45 | 3.2 | 4.53 | 6.67 | 7.19 | 13.76 |
EBIT | 33.63 | -106.6 | -94.71 | -88.92 | -74.61 | -91.41 |
EBIT Margin | 21.43% | - | - | - | -277.25% | - |
Revenue as Reported | 156.94 | 9.68 | 3.93 | 6.23 | 26.91 | 14.27 |